This brand name is authorized in Japan
The drug POLIDOCASKLEROL contains one active pharmaceutical ingredient (API):
|
1
Polidocanol
UNII 0AWH8BFG9A - POLIDOCANOL
|
|
Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05BB02 | Polidocanol | C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BB Sclerosing agents for local injection |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3329405A2029, 3329405A3025, 3329405A4021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
